ȸ»ç¼Ò°³
Á¦Ç°¼Ò°³
¿¬±¸°³¹ß
È«º¸¼¾ÅÍ
ä¿ëÁ¤º¸
°í°´Áö¿ø
CEOÀλ縻
¿¬Çõ
VISION
Á¶Á÷µµ
IR
- °æ¿µÁ¤º¸
- À繫Á¤º¸
- ÁÖ½ÄÁ¤º¸
- °ø½Ã»çÇ×
- °øÁö»çÇ×
- ÅõÀÚ¹®ÀÇ
CP
ã¾Æ¿À½Ã´Â±æ
Çã°¡º¯°æ»çÇ×
Á¦Ç°Á¤º¸
Á¦Ç°°Ë»ö
R&D VISION
Á¶Á÷µµ
¿¬Çõ ¹× ¿¬±¸½ÇÀû
¿¬±¸°³¹ßÇ°¸ñ
PRODUCT PIPELINE
INTERNATIONAL NETWORK
»õ¼Ò½Ä
CI¼Ò°³
µ¿¿µ»óÀÚ·á½Ç
ÀμⱤ°í
µðÁöÅкê·Î¼Å
ÀÎÀç»ó
º¹¸®ÈÄ»ý
ä¿ë°ø°í
FAQ
FAQ
°í°´°Ô½ÃÆÇ
ÀÔÂûÁ¤º¸
HOME
|
SITEMAP
|
ENGLISH
HOME > Á¦Ç°¼Ò°³ >
Çã°¡º¯°æ»çÇ×
459
½´¹ÙÁ¬Á¤, ½´½ºÅ¸Á¤ »ç¿ë»óÀÇ ÁÖÀÇ»çÇ× º¯°æ
F_2023011716344870.pdf
2023-01-12
152
ÀǾàÇ°¾ÈÀüÆò°¡°ú-7881È£('22.12.21.)¿¡ µû¶ó
½´¹ÙÁ¬Á¤10/10mg,½´¹ÙÁ¬Á¤10/20mg,½´¹ÙÁ¬Á¤10/5mg,
½´½ºÅ¸Á¤5mg,½´½ºÅ¸Á¤10mg,½´½ºÅ¸Á¤20mg
ÀÇ
»ç¿ë»óÀÇ ÁÖÀÇ»çÇ×
ÀÌ 2023³â 04¿ù 06ÀÏ ÀÌÈÄ
º¯°æ
µÊÀ» ¾Ë·Áµå¸³´Ï´Ù.
·çÆÄÇÉÁ¤(·çÆÄŸµòǪ¸¶¸£»ê¿°) ȯÀÚ¿ë¼³¸í¼
¾È±¹·Ï¼ÒÇÁ·ÎÆ泪Ʈ·ýÁ¤ »ç¿ë»óÀÇ ÁÖÀÇ»çÇ× º¯°æ
FAMILY SITE
¾È±¹°Ç°(ÁÖ)
»çÀ̹ö °¨»çÆÀ
º´¿ªÀÌÇà ³×ºñ°ÔÀ̼Ç
Gallery AG
¾È±¹¹ÙÀÌ¿ÀÁø´Ü